Facebook
Twitter
Telegram
Report an ErrorGlobal Medical REIT Balance Sheet 2011-2024 | GMRE
Annual Balance Sheet Global Medical REIT
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | 383 M | 311 M | 198 M | 47.3 M | 54.8 M | 39.1 M | -3.52 K | -12.3 K | -47.4 K |
Long Term Debt |
- | - | - | - | 38.6 M | 315 M | 203 M | 66.5 M | 63.9 M | 19.6 M | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 59.3 M | 325 M | 207 M | 67.5 M | 63.9 M | 19.6 M | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | 19.4 K | 7.88 K | - |
Total Liabilities |
662 M | 744 M | 626 M | 643 M | 425 M | 336 M | 216 M | 72.3 M | 65.5 M | 20 M | 19.4 K | 7.88 K | 380 |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-239 M | -199 M | -157 M | -117 M | -71.4 M | -45 M | -34.4 M | -17 M | -3.15 M | -791 K | -95.9 K | -50.6 K | -459 |
Total Assets |
1.27 B | 1.39 B | 1.26 B | 1.1 B | 885 M | 636 M | 475 M | 227 M | 65.3 M | 22.2 M | 3.52 K | 12.3 K | 54.9 K |
Cash and Cash Equivalents |
1.28 M | 4.02 M | 12.8 M | 10.8 M | 2.76 M | 3.63 M | 5.11 M | 19.7 M | 9.18 M | 88.8 K | 3.47 K | 12.3 K | 47.4 K |
Book Value |
606 M | 649 M | 638 M | 458 M | 460 M | 300 M | 259 M | 155 M | -139 K | 2.22 M | -15.9 K | 4.43 K | 54.5 K |
Total Shareholders Equity |
584 M | 633 M | 638 M | 458 M | 430 M | 269 M | 246 M | 155 M | -139 K | 1.73 M | -15.9 K | 4.43 K | - |
All numbers in USD currency
Quarterly Balance Sheet Global Medical REIT
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
25.7 M | - | - | - | - | - | - | - | 24.1 M | - | 23.9 M | 18 M | 18.9 M | 19.4 M | 9.23 M | 7.3 M | 11 M | 11 M | 10.9 M | - | - | 9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
666 M | 662 M | 669 M | 679 M | 741 M | 744 M | 742 M | - | 633 M | 626 M | 613 M | 563 M | 540 M | 643 M | 643 M | 643 M | 643 M | 425 M | 425 M | 425 M | 425 M | 336 M | 336 M | 336 M | 336 M | 213 M | 213 M | 216 M | 216 M | 72.3 M | 72.3 M | 72.3 M | 83.3 M | 65.5 M | 65.5 M | 65.5 M | 65.5 M | 22.6 M | 22.9 M | 22.9 M | 22.9 M | - | 19.4 K | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-252 M | -239 M | -224 M | -214 M | -212 M | -199 M | -185 M | - | -168 M | -157 M | -148 M | -138 M | -127 M | -117 M | -117 M | -117 M | -117 M | -71.4 M | -71.4 M | -71.4 M | -71.4 M | -45 M | -45 M | -45 M | -45 M | -34.4 M | -34.4 M | - | - | - | - | - | - | -3.15 M | -2.3 M | -1.73 M | -1.54 M | -1.29 M | -1.29 M | -1.29 M | -1.29 M | 104 K | -95.9 K | 88.3 K | 81.8 K | 78.2 K | 50.6 K | - | - | - | - | - | - |
Total Assets |
1.26 B | 1.27 B | 1.3 B | 1.32 B | 1.37 B | 1.39 B | 1.41 B | - | 1.29 B | 1.26 B | 1.24 B | 1.2 B | 1.14 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 885 M | 885 M | 885 M | 885 M | 636 M | 636 M | 636 M | 636 M | 472 M | 472 M | 475 M | 475 M | 227 M | 227 M | 227 M | 96.1 M | 65.3 M | 65.3 M | 65.3 M | 65.3 M | 24.3 M | 24.6 M | 24.6 M | 24.6 M | - | 3.52 K | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.33 M | 1.28 M | 1.28 M | 2.46 M | 4.6 M | 4.02 M | 3.2 M | 5.87 M | 1.85 M | 7.21 M | 6.03 M | 5.82 M | 5.3 M | 5.51 M | 5.51 M | 5.51 M | 5.51 M | 2.76 M | 2.76 M | 2.76 M | 2.76 M | 3.63 M | 3.63 M | 3.63 M | 3.63 M | 5.11 M | 5.11 M | 5.11 M | 5.11 M | 19.7 M | 19.7 M | 19.7 M | 507 K | 9.18 M | 9.18 M | 9.18 M | 369 K | 89 K | 301 K | 301 K | 301 K | 3.5 K | 3.52 K | 3.52 K | 3.47 K | 11.2 K | 12.3 K | 12.3 K | 11.2 K | 47.3 K | 47.4 K | 47.4 K | - |
Book Value |
597 M | 606 M | 634 M | 641 M | 628 M | 649 M | 665 M | - | 653 M | 638 M | 630 M | 637 M | 596 M | 458 M | 458 M | 458 M | 458 M | 460 M | 460 M | 460 M | 460 M | 300 M | 300 M | 300 M | 300 M | 259 M | 259 M | 259 M | 259 M | 155 M | 155 M | 155 M | 12.8 M | -139 K | -139 K | -139 K | -139 K | 1.73 M | 1.73 M | 1.73 M | 1.73 M | - | -15.9 K | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
575 M | 584 M | 611 M | 620 M | 628 M | 633 M | 665 M | 649 M | 653 M | 623 M | 630 M | 623 M | 582 M | 445 M | 445 M | 445 M | 445 M | 430 M | 430 M | 430 M | 430 M | 269 M | 269 M | 269 M | 269 M | 246 M | 246 M | 246 M | 246 M | 155 M | 155 M | 155 M | 12.8 M | -139 K | -139 K | -139 K | -139 K | 1.73 M | 1.73 M | 1.73 M | 1.73 M | -23.6 K | -15.9 K | -15.9 K | 15.9 K | 1.81 K | 4.43 K | 4.43 K | 4.43 K | - | 54.5 K | 54.5 K | - |
All numbers in USD currency